The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 20, 2024

Filed:

Feb. 17, 2022
Applicant:

University of Virginia Patent Foundation, Charlottesville, VA (US);

Inventors:

John C. Herr, Charlottesville, VA (US);

Alexander L. Klibanov, Charlottesville, VA (US);

Kevin Simon Eisenfrats, Charlottesville, VA (US);

Assignee:

University of Virginia Patent Foundation, Charlottesville, VA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 17/34 (2006.01); A61F 6/22 (2006.01); A61L 24/00 (2006.01); A61L 24/06 (2006.01); A61L 27/52 (2006.01); A61L 27/54 (2006.01); A61K 49/22 (2006.01); A61B 8/08 (2006.01); A61B 17/12 (2006.01); A61B 17/42 (2006.01);
U.S. Cl.
CPC ...
A61L 24/06 (2013.01); A61B 8/085 (2013.01); A61B 8/0833 (2013.01); A61B 8/0841 (2013.01); A61B 17/12 (2013.01); A61B 17/12022 (2013.01); A61B 17/12186 (2013.01); A61B 17/3403 (2013.01); A61F 6/22 (2013.01); A61K 49/223 (2013.01); A61K 49/226 (2013.01); A61L 24/001 (2013.01); A61L 24/0015 (2013.01); A61L 24/0031 (2013.01); A61L 24/0036 (2013.01); A61L 27/52 (2013.01); A61L 27/54 (2013.01); A61B 8/0891 (2013.01); A61B 8/481 (2013.01); A61B 8/488 (2013.01); A61B 17/42 (2013.01); A61B 2017/3413 (2013.01); A61L 2300/626 (2013.01); A61L 2400/06 (2013.01); A61L 2430/36 (2013.01);
Abstract

Disclosed are methods of delivering an agent to the lumen of the vas deferens under guidance of ultrasound imaging. The methods include vas-occlusive contraception in which the vas deferens is non-surgically isolated and an occlusive substance is percutaneously administered into the lumen of the vas deferens under ultrasound. Also disclosed are methods of reversal of vas-occlusive contraception and methods of delivering an agent to the lumen of the vas deferens. Also disclosed are compositions for use in the methods of the invention.


Find Patent Forward Citations

Loading…